| Benefits of reduced mortality were seen in over-75s as well as younger patients Related items from OnMedica Overview of risk assessment and statin therapy Reducing threshold for statins even further might be cost-effective Major review clears statins New alternative to statins gets regulatory green light Never too old to benefit from CVD prevention |
No comments:
Post a Comment